Jump to menu.Jump to contents.

ARISE

Home > ARISE

ARISE_HP.png
We launched the new ARISE website on 1st March 2023.
Please visit here!

INTRODUCTION

Global collaboration in clinical research is necessary to jointly address common global health issues and to provide evidence-based solutions to patients and health professionals as fast as possible. Multinational cooperation is essential for clinical research to make patient access to study results faster. However, there are many challenges to be overcome in the R&D process.

Conducting multinational researches is further complex, due to differences in regulatory and ethical requirements among countries, differences in medical systems, differences in ethnic and health priorities, and so on. These barriers affect the scope of research and cause its potential impact on the health care industry, health economy, and society.

To resolve these issues and promote and accelerate global clinical researches, we will work with partners leading to a common goal of contributing to global health. Member organizations shall, as much as possible, share their experiences and resources that are difficult to obtain in a single institute.

MEMBER ORGANIZATION

  • National Center for Global Health and Medicine
  • Nagasaki University
  • Osaka University
  • International University of Health and Welfare
  • University of Indonesia
  • Faculty of Medicine Siriraj Hospital, Mahidol University
  • University of the Philippines Manila

 ariseorg

ACTIVITIES

VISION

ARISE contributes to enhancing health and reducing illness and disability by promoting a network of AROs in the Asian region.

MISSION

ARISE strives to achieve the following missions through efficient and effective collaboration with member organizations and stakeholders.

  1.  Promotes the integrity, safety, ethics, and quality of investigator-initiated clinical studies.
  2.  Contributes to developing innovative medical products to address unmet health needs and diseases of public health significance in the region.
  3.  Contributes to improving the resources and capacity of clinical study sites in the region.
  4.  Accelerates clinical studies and improves timelines and processes for authorization.
  5.  Promotes Public-Academic-Private-Partnerships (PAPPs) in the region.
  6.  Bridges the gap between sciences and policy for health.

SECRETARIAT OFFICE

Department of International Trials Central for Clinical Sciences National Center for Global Health and Medicine 1-21-1, Toyama, Shinjuku, Tokyo 162-8655 JAPAN Tel : +81-3-6228-0445